Cargando…
CDK9 Expression Shows Role as a Potential Prognostic Biomarker in Breast Cancer Patients Who Fail to Achieve Pathologic Complete Response after Neoadjuvant Chemotherapy
Failure to achieve pathologic complete response is associated with poor prognosis in breast cancer patients following neoadjuvant chemotherapy (NACT). However, prognostic biomarkers for clinical outcome are unclear in this patient population. Cyclin-dependent kinase 9 (CDK9) is often dysregulated in...
Autores principales: | Schlafstein, Ashley J., Withers, Allison E., Rudra, Soumon, Danelia, Diana, Switchenko, Jeffrey M., Mister, Donna, Harari, Saul, Zhang, Hui, Daddacha, Waaqo, Ehdaivand, Shahrzad, Li, Xiaoxian, Torres, Mylin A., Yu, David S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204190/ https://www.ncbi.nlm.nih.gov/pubmed/30405916 http://dx.doi.org/10.1155/2018/6945129 |
Ejemplares similares
-
Locoregional and Distant Recurrence Patterns in Young versus Elderly Women Treated for Breast Cancer
por: Rudra, Soumon, et al.
Publicado: (2015) -
Locoregional Recurrence Risk in Breast Cancer Patients with Estrogen Receptor Positive Tumors and Residual Nodal Disease following Neoadjuvant Chemotherapy and Mastectomy without Radiation Therapy
por: Kandula, Shravan, et al.
Publicado: (2015) -
Neoadjuvant Hormonal Therapy is Associated with Comparable Outcomes to Neoadjuvant Chemotherapy in Post-Menopausal Women with Estrogen Receptor-Positive Breast Cancer
por: Marcus, David M., et al.
Publicado: (2013) -
A gemcitabine sensitivity screen identifies a role for NEK9 in the replication stress response
por: Smith, Scott C., et al.
Publicado: (2014) -
A prospective study of quality of life in breast cancer patients undergoing radiation therapy
por: Xiao, Canhua, et al.
Publicado: (2016)